Skip to main content
Dryad

Latency to fall in rotarod task for mice tested with various inhibition of cerebellar nuclei neurons and corresponding control groups

Data files

Abstract

This dataset represents the latency to fall in fixed-speed and accelerating rotarod tasks in mice. The accelerating rotarod protocol is conducted over 7 days, with 7 trials per day for each mouse. In the fixed-speed rotarod protocol, each mouse is exposed to each speed once.

Two sets of experiments are included. In the first set, mice receive either sham or adeno-associated virus (AAV) bilateral injections into the cerebellar nuclei (CN) to express an genetically engineered receptor (Designer Receptor Exclusively Activated by Designer Drugs or "DREADD") inhibiting the neurons when activated by the synthetic molecule (clozapine-N-oxyide, CNO). Mice in both the sham and DREADD groups perform the rotarod task either with CNO or saline administered during the 7 days of training, or with CNO/saline administered after each session to assess effects on the overnight consolidation of the learning that took place within each day.

In the second set of experiments, the effect of selective inhibition of CN subpopulation is investigated. All mice receive AAV injections to express the inhibitory DREADD selectively in neurons projecting to either the centrolateral thalamus (CN–CL mice) or the ventral anterior lateral thalamus (CN–VAL mice). These mice receive either saline or CNO over the 7 days. In these groups, treatments are administered either during the learning phase or after each session.

Overall, this dataset enables the study of the effects of inhibiting cerebellar output on motor learning.